SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
New Phase 2 Data From Brain Cancer Study With Agenus (Formerly known as Antigenics Inc. - New York)' Prophage Vaccine (HSPPC-96) Presented at Plenary Session of AANS